leukotriene receptor antagonist
Montelukast, a cysteinyl leukotriene receptor antagonist, is being developed for        the treatment of asthma and related diseases.
Montelukast, a cysteinyl  @SUBJECT$ , is being developed for        the  @PREDICAT$  of  @OBJECT$  and related diseases.